The demedicalization of methadone maintenance
- PMID: 7562261
- DOI: 10.1080/02791072.1995.10471683
The demedicalization of methadone maintenance
Abstract
The institution of methadone maintenance as a treatment modality for heroin addiction in the mid-1960s was part of the growing medicalization of social problems in the United States. The definition of deviance as "sickness" rather than "badness" set the stage for America's first harm-reduction strategy. By the 1970s methadone maintenance was seen as a way to reduce drug-related crime, and federally funded programs proliferated. Accompanying methadone's phenomenal expansion was increased regulation, bureaucratization, and criticism. The early 1980s brought the Reagan era, fiscal austerity, the new "just say no" abstinence morality, and demedicalization of methadone maintenance. By the time needle-sharing was recognized as a major contributing factor in the spread of HIV, methadone had been transformed into a largely fee-for-service, short-term, begrudgingly tolerated treatment modality. Ironically, while other countries were able to use methadone to curb the spread of AIDS, the United States refused to facilitate its expansion, and in fact impeded it. To the frustration of proponents and consumers, this original harm-reduction tool, with the potential to impact the epidemic, was demedicalized and remains marginalized.
Similar articles
-
Prescriptions, power and politics: the turbulent history of methadone maintenance in Canada.J Public Health Policy. 2000;21(2):187-210. J Public Health Policy. 2000. PMID: 10881454
-
Methadone maintenance treatment (MMT): a review of historical and clinical issues.Mt Sinai J Med. 2000 Oct-Nov;67(5-6):347-64. Mt Sinai J Med. 2000. PMID: 11064485 Review.
-
"Maintenance" treatment of addiction: to whose credit, and why it matters.Int J Drug Policy. 2009 Jan;20(1):1-3. doi: 10.1016/j.drugpo.2008.07.001. Epub 2008 Sep 4. Int J Drug Policy. 2009. PMID: 18775657 No abstract available.
-
Methadone maintenance treatment: disciplining the 'addict'.Health History. 2011;13(2):130-57. doi: 10.5401/healthhist.13.2.0130. Health History. 2011. PMID: 22329263
-
Drug use and HIV/AIDS in China.Drug Alcohol Rev. 2006 Mar;25(2):173-5. doi: 10.1080/09595230500538835. Drug Alcohol Rev. 2006. PMID: 16627308 Review.
Cited by
-
Structural barriers in the context of opiate substitution treatment in Germany--a survey among physicians in primary care.Subst Abuse Treat Prev Policy. 2013 Jul 22;8:26. doi: 10.1186/1747-597X-8-26. Subst Abuse Treat Prev Policy. 2013. PMID: 23875627 Free PMC article.
-
A transition of power in opioid substitution treatment: Clinic managers' views on the consequences of a patient choice reform.Nordisk Alkohol Nark. 2022 Jun;39(3):279-300. doi: 10.1177/14550725221075003. Epub 2022 Feb 1. Nordisk Alkohol Nark. 2022. PMID: 35720521 Free PMC article.
-
Drug treatment outcomes for persons on waiting lists.Am J Drug Alcohol Abuse. 2008;34(5):526-33. doi: 10.1080/00952990802146340. Am J Drug Alcohol Abuse. 2008. PMID: 18618338 Free PMC article.
-
Does "difficult patient" status contribute to de facto demedicalization? The case of borderline personality disorder.Soc Sci Med. 2015 Oct;142:82-9. doi: 10.1016/j.socscimed.2015.08.008. Epub 2015 Aug 7. Soc Sci Med. 2015. PMID: 26298091 Free PMC article.
-
Socio-spatial stigmatization and the contested space of addiction treatment: remapping strategies of opposition to the disorder of drugs.Soc Sci Med. 2010 Mar;70(6):859-66. doi: 10.1016/j.socscimed.2009.10.033. Epub 2009 Nov 26. Soc Sci Med. 2010. PMID: 19944509 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical